Clinical Context
A 42-year-old patient with moderate-to-severe plaque psoriasis requires maintenance biologic therapy with a ustekinumab biosimilar, supplied as Q5099 (injection, ustekinumab-stba (Steqeyma), biosimilar, 1 mg). The patient presents to an outpatient infusion or injection suite in a dermatology or rheumatology clinic for a scheduled subcutaneous dose. Clinical workflow includes verification of prescription and prior authorization, medication preparation by pharmacy, clinical assessment for active infections or contraindications, informed consent, administration of the subcutaneous injection by a licensed clinician, observation for immediate adverse reactions (typically 15–30 minutes), documentation of lot number and dose in the medical record, and scheduling of the next maintenance dose.
Typical site of service is an outpatient clinic or physician office (dermatology, rheumatology, or specialty biologic injection center). Common patient scenarios include initiation after induction with weight-based dosing or ongoing maintenance dosing at manufacturer-specified intervals for conditions such as plaque psoriasis, psoriatic arthritis, or Crohn disease.
Coding Specifications
| Modifier | Description | When to Use |
|---|
00 | Standard — no modifier | Use when no special circumstances apply to the service. |
| 22 | Increased procedural services | Use when work required to administer the injection is substantially greater than typical (rare for standard subcutaneous biologic but applicable if complex access or prolonged monitoring occurred).
| 23 | Unusual anesthesia | Use if significant, medically necessary anesthesia was required for administration (rare for subcutaneous injection).
| 52 | Reduced services | Use when the service was partially reduced or not completed as normally required.
| 53 | Discontinued procedure | Use when the administration was started but discontinued due to patient condition or adverse event.
| 62 | Two surgeons | Use when two providers of different specialties are required to perform the procedure (uncommon for this injection).
| 78 | Unplanned return to operating/procedure room for related procedure during postoperative period | Use if the patient required an unplanned return for a related procedure (rare for injection services).
| 80 | Assistant at surgery | Use when an assistant surgeon is required (generally not applicable to subcutaneous injection but included when applicable).
| 82 | Assistant at surgery, when qualified resident surgeon not available | Use when a qualified assistant is required and no resident is available (rare for injection).
| AS | Physician assistant, nurse practitioner, or clinical nurse specialist service | Use to indicate service performed by these nonphysician practitioners when allowed by payer rules.
| QK | Medical direction of two, three, or four concurrent anesthesia procedures involving qualified individuals | Not typically applicable to this injection; include only when anesthesia services meet criteria.
| QX | CRNA service with medical direction by a physician | Use when a certified registered nurse anesthetist provides anesthesia under medical direction (rare for this service).
| QY | Medical direction of one CRNA by an anesthesiologist | Use when applicable to anesthesia-related circumstances.
| TG | Graduate medical education (GME) primary care exception | Use when applicable to teaching physician/GME billing rules.
| Taxonomy Code | Specialty | Notes |
|---|
207N00000X | Dermatology | Dermatologists commonly prescribe and oversee biologic therapy for psoriasis and related skin conditions. |
| 2086S0105X | Rheumatology | Rheumatologists manage biologic therapy for psoriatic arthritis and other inflammatory arthropathies.
| 207RH0000X | Gastroenterology | Gastroenterologists prescribe biologics for Crohn disease and ulcerative colitis when ustekinumab is indicated.
| 363L00000X | Nurse Practitioner | Nurse practitioners frequently administer and follow patients on maintenance biologic injections in outpatient clinics.
| 207Q00000X | Physician Assistant | Physician assistants often provide injection services and follow-up care under supervising physician protocols.
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|
L40.0 | Psoriasis vulgaris | Primary indication for ustekinumab therapy in moderate-to-severe plaque psoriasis. |
| L40.50 | Arthropathic psoriasis, unspecified | Relevant when psoriatic arthritis coexists and biologic therapy is indicated.
| M07.0 | Distal interphalangeal psoriatic arthropathy | Specific psoriatic arthropathy managed with biologic agents.
| K50.90 | Crohn disease, unspecified, without complications | Ustekinumab is indicated for moderate-to-severe Crohn disease in certain patients.
| K51.90 | Ulcerative colitis, unspecified, without complications | Relevant when ustekinumab is considered for inflammatory bowel disease management.
| L40.8 | Other psoriasis | Covers less common presentations of psoriasis treated with biologics.
| R50.9 | Fever, unspecified | Important to document and assess before biologic administration due to infection risk.
| Z79.899 | Other long term (current) drug therapy | Used to indicate ongoing long-term biologic therapy on the medication list.
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|
96372 | Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | Commonly reported for the administration of a subcutaneous biologic when payers require a CPT for the injection service alongside the HCPCS J/Q code for the drug. |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, typically 15 minutes | Often used for the prescribing provider visit, medication assessment, or routine follow-up before administration.
| 36415 | Collection of venous blood by venipuncture | Performed when laboratory monitoring (e.g., baseline CBC, liver tests, or drug-level monitoring) is required prior to or during biologic therapy.
| 99406 | Smoking and tobacco use cessation counseling, intermediate, greater than 3 minutes up to 10 minutes | Ancillary counseling services that may be provided during a visit; included as an example of common ancillary E/M-related services (use appropriate counseling codes per documentation).
| 99070 | Supplies and materials provided by the physician over and above those usually included with the office visit | Use for any additional non-covered supplies related to preparation or administration of the biologic (subject to payer policies).